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OBJECTIVES The aim of this study was to assess the incremental value of exercise echocardiography for the
risk stratification of diabetic patients.
BACKGROUND There are currently insufficient outcome data in diabetic patients to define the role of stress
echocardiography as a prognostic tool.
METHODS We studied the prognostic value of exercise echocardiography in 563 patients with diabetes
mellitus (mean age 64 6 11 years, 336 men) and known or suspected ischemic heart disease
(IHD).
RESULTS Cardiac events occurred in 50 patients (cardiac death in 23 and nonfatal myocardial infarction
[MI] in 27) during a median follow-up period of three years. Event rate was lower in patients
with normal as compared to those with abnormal exercise echocardiography at one year (0%
vs. 1.9%), three years (1.8% vs. 11.9%), and five years (7.6% vs. 23.3%), respectively (p 5
0.0001). Patients with multivessel distribution of echocardiographic abnormalities had the
highest event rate (2.9% at one year, 15.2% at three years, and 32.8% at five years). In an
incremental multivariate analysis model, exercise echocardiography increased the chi-square
of the clinical and exercise ECG model from 29 to 44.8 (p 5 0.0001).
CONCLUSIONS Exercise echocardiography provides incremental data for risk stratification of diabetic patients
with known or suspected IHD. Patients with a normal exercise echocardiogram have a low
event rate. Patients with multivessel distribution of exercise echocardiographic abnormalities
are at the highest risk of cardiac events, as one-third of these patients experience cardiac death
or nonfatal MI during the five years following exercise echocardiography. (J Am Coll Cardiol
2001;37:1551–7) © 2001 by the American College of Cardiology
Diabetes mellitus is a major risk factor for cardiovascular
morbidity and mortality (1,2). Ischemic heart disease (IHD)
is the leading cause of death in diabetic patients, and the
related risk is independent of other conventional risk factors
for IHD (3–5). Additionally, diabetic patients were shown
to have a higher morbidity after acute myocardial infarction
(MI) than nondiabetic patients (6). Therefore, the nonin-
vasive diagnosis and risk stratification of IHD in diabetic
patients is important for the selection and optimization of
therapeutic interventions, which may improve survival and
reduce complications of IHD in this population (1,7–10).
Exercise electrocardiography is the most widely used test for
the diagnosis and functional evaluation of IHD (11,12).
However, the value of the test may be limited by the
presence of baseline ST-segment abnormalities as well as by
the presence of exercise-induced myocardial ischemia. Be-
cause of these limitations, the American Diabetes Associa-
tion and the American College of Cardiology recommended
the use of exercise myocardial perfusion imaging for prog-
nostic stratification of diabetic patients, based on the pub-
lished data of the incremental prognostic value of this
method in patients with and without diabetes mellitus
(1,13). It was concluded that there are currently insufficient
outcome data in diabetic patients following stress echocar-
diography to define its role as a prognostic tool (1).
Therefore, the aim of this study was to evaluate the
incremental value of exercise echocardiography for the risk
stratification of diabetic patients with known or suspected
IHD, relative to clinical data.
METHODS
Patients. The study included 631 patients with diabetes
mellitus who underwent exercise echocardiography at the
Mayo Clinic, Rochester, Minnesota, between January 1990
and December 1995. Diabetes mellitus was defined by the
presence of a fasting blood glucose $140 mg/dl on at least
two occasions or requirement for insulin or oral hypoglyce-
mic agents. The Institutional Review Board approved the
study. Twelve patients (2%) were excluded because they
declined participation in research or refused to provide
follow-up status, and 33 patients (5%) were excluded
because of inadequate echocardiographic images. Twenty-
three patients (4%) were lost to follow-up. The final
population of the study consisted of 563 patients.
Exercise echocardiography protocol. Patients underwent
symptom-limited treadmill exercise testing according to the
Bruce protocol in 82%, Naughton protocol in 10%, and
modified Bruce protocol in 8%. Both standard blood pres-
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sure and 12-channel electrocardiographic (ECG) monitor-
ing were performed. Two-dimensional echocardiographic
images were obtained from the standard parasternal and
apical windows before and immediately after exercise. Both
digitized and videotape-recorded images were used for
interpretation of the studies (14). Ejection fraction at rest
was measured using a previously validated modification of
the method of Quinones et al. (15) or by visual estimation
(16). Regional wall motion was assessed semiquantitatively
by an echocardiographer, blinded to clinical information.
Wall motion at rest and with exercise was scored 1 through
5 according to a 16-segment model (17). Wall motion score
index was determined at rest and exercise as the sum of the
segmental scores divided by the number of visualized
segments. The difference between exercise and rest wall
motion score index was reported as D wall motion score
index. The development of new or worsening wall motion
abnormalities (WMA) was considered indicative of myo-
cardial ischemia. A WMA present at rest and unchanged
with exercise was classified as fixed. Exercise echocardiog-
raphy results were defined as abnormal if there was ischemia
or fixed WMA (18).
To assess the number of vascular regions with echocar-
diographic abnormalities, the anterior, apical, anteroseptal,
and midinferoseptal segments were assigned to the left
anterior descending coronary artery, the anterolateral and
inferolateral segments to the left circumflex, and the inferior
and basal inferoseptal segments to the right coronary artery.
The exercise ECG was considered positive for ischemia if
there was horizontal or downsloping ST-segment depres-
sion of $1 mm at 80 ms after the J-point, nondiagnostic if
the baseline ST-segment was abnormal or if the patient was
receiving digitalis, and negative for ischemia in the absence
of the criteria described in the previous text. Workload was
measured by metabolic equivalents (METs).
Follow-up. Follow-up was obtained by mailed question-
naires and scripted telephone interviews. Events were veri-
fied by contacting the patients’ primary physician and
reviewing medical records and death certificates. The end
points considered were hard cardiac events defined as
nonfatal MI and cardiac death. Sudden unexpected death
occurring without another explanation was included as
cardiac death. Coronary revascularization procedures during
the follow-up period were also noted. Patients who had
revascularization before other events were censored at the
time of revascularization.
Statistical analysis. Continuous variables were reported as
mean 6 SD, and comparisons between groups were based
on the Wilcoxon rank-sum test. Categorical variables were
summarized as percentages, and group comparisons were
based on the chi-square test. Survival free of the end point
of interest was estimated by the Kaplan-Meier method.
Univariable and multivariable associations of clinical and
exercise echocardiographic variables with the end points
were assessed in the Cox proportional hazards framework.
Variables were selected in a stepwise forward selection
manner with entry and retention set at a significance level of
0.05. Results of these analyses were summarized as risk
ratios with corresponding 95% confidence intervals. The
incremental value of exercise echocardiographic information
over clinical and exercise ECG data was assessed in four
modeling steps. The first step consisted of fitting a multi-
variable model of only clinical data. Variables selected from
the first step were then used as baseline risk factors, and
exercise ECG and hemodynamic variables were added in a
stepwise forward selection manner. Variables selected from
the first two steps were then used as a baseline risk model,
and rest echocardiographic variables were added to this
model in a stepwise forward selection manner. In the final
step, exercise echocardiographic abnormalities were added.
RESULTS
The mean age of the study group was 64 6 11 years. There
were 336 men and 227 women. Two hundred twenty-five
patients (40%) were receiving insulin (with or without
concomitant oral hypoglycemic agents), 261 patients (46%)
were receiving oral hypoglycemic agents, and 77 (14%) were
treated by diet alone. One hundred sixty-eight patients
(30%) had previous MI and 155 (30%) had previous
myocardial revascularization (coronary artery bypass graft-
ing in 60, angioplasty in 79, and both procedures in 16
patients). Hypertension was present in 362 patients (64%),
hypercholesterolemia in 337 patients (60%), and smoking in
318 patients (57%). Reasons for termination of the exercise
stress test were fatigue in 344 patients (61%), dyspnea in
111 (20%), angina in 33 (6%), arrhythmias in 4 (0.7%),
ST-segment changes in 10 (2%), and leg distress in 61
(11%).
Eighty-four patients underwent coronary revasculariza-
tion prior to any cardiac event and were censored. Revas-
cularization was performed early (,3 months) in 27 patients
and late in 57 patients. Patients who underwent revascular-
ization were more likely to have had ischemia by echocar-
diography (63% vs. 37%, p , 0.001), exercise-induced
angina (24% vs. 7%, p , 0.001), and ECG evidence of
ischemia (45% vs. 20%, p , 0.0001).
During a median follow-up of three years (maximum
eight years), 50 hard cardiac events occurred at a median of
2.5 years (range five days to seven years) after the test. These
consisted of cardiac death in 23 patients and nonfatal MI in
27 patients. Event-free survival was 99% at one year, 97% at
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
IHD 5 ischemic heart disease
METs 5 metabolic equivalents
MI 5 myocardial infarction
WMA 5 wall motion abnormalities
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three years, and 83% at five years. Table 1 demonstrates the
clinical features of patients with and without cardiac events.
Echocardiographic data. Resting WMA were detected in
241 patients (43%). Among these patients, 134 (56%) had a
history of previous MI, 104 (43%) had Q-waves on baseline
ECG, and 87 (36%) had resting WMA in absence of a
history of MI or Q-waves on the baseline ECG. The
exercise echocardiogram was abnormal in 340 patients
(60%). Ischemia (exercise-induced WMA) was detected in
229 patients (41%). Of these patients, 130 (57%) also had
resting WMA. Among the 229 patients with exercise-
induced WMA, 81 (35%) had a history of typical angina, 34
(15%) had angina during the test, and 89 (39%) had a
positive exercise ECG. No significant differences were seen
among patients receiving insulin, oral hypoglycemic agents,
and those treated by diet alone with regard to the incidence
of an abnormal stress echocardiogram (60%, 59%, and 66%)
or the incidence of ischemia by exercise echocardiography
(42%, 39%, and 44%), respectively.
Hemodynamic and echocardiographic features of
patients with and without events. Table 2 demonstrates
the hemodynamic and exercise echocardiographic data in
patients with and without hard cardiac events. No signifi-
cant differences were detected between patients with and
without events regarding heart rate, systolic blood pressure,
and rate pressure product at rest or at maximal exercise.
Patients with cardiac events achieved a lower workload. The
ECG was more frequently nondiagnostic in patients with
cardiac events.
Patients with cardiac events had a higher wall motion
score index, both at rest and with exercise, a lower resting
ejection fraction, a larger difference between rest and exer-
cise wall motion score index, and a larger percentage of
ischemic segments as compared to patients without cardiac
events (Table 2). Clinical, exercise stress and echocardio-
graphic variables associated with an increased risk of hard
Table 1. Clinical Features of Patients With and Without Hard
Cardiac Events
Clinical Features
No Events
(n 5 513)
Events
(n 5 50)
p
Value
Age (yrs) 64 6 11 67 6 10 0.07
Men 301 (59%) 35 (70%) 0.1
History of typical angina 125 (24%) 14 (28%) 0.7
Reasons for referral
z Evaluation of chest pain or
dyspnea
310 (60%) 21 (42%) 0.01
z Preoperative assessment
z Positive or nondiagnostic
exercise
20 (4%) 1 (2%) 0.4
ECG 20 (4%) 1 (2%) 0.5
z Functional assessment after
myocardial infarction
80 (16%) 22 (44%) 0.01
z Evaluation of risk factors 83 (16%) 5 (4%) 0.2
Hypercholesterolemia 303 (59%) 34 (68%) 0.2
Cigarette smoking 282 (55%) 36 (72%) 0.02
Systemic hypertension 332 (65%) 30 (60%) 0.5
Family history of IHD 233 (46%) 30 (60%) 0.2
Previous myocardial
infarction
138 (27%) 30 (60%) 0.0001
Medications
Beta-blocker therapy 144 (28%) 10 (20%) 0.2
Calcium channel-blocker
therapy
214 (42%) 21 (42%) 0.9
Diabetes management
Insulin 208 (41%) 17 (34%) 0.07
Oral hypoglycemic agents 234 (46%) 27 (54%)
Diet only 71 (13%) 6 (12%)
ECG 5 electrocardiogram; IHD 5 ischemic heart disease.
Table 2. Exercise Stress Test and Echocardiographic Data of Patients With and Without
Cardiac Events
Variable No events (n 5 513) Events (n 5 50) p Value
Resting heart rate 76 6 14 79 6 14 0.1
Peak heart rate 136 6 22 135 6 26 0.8
Rest systolic blood pressure 140 6 22 140 6 19 0.9
Exercise systolic blood pressure 181 6 31 175 6 34 0.2
D Systolic blood pressure 41 6 29 35 6 36 0.1
Exercise rate pressure product 24,864 6 6,725 23,970 6 7,919 0.3
Workload (METS) 7.4 6 2.5 6.4 6 2.9 0.02
Angina during the test 46 (9%) 8 (16%) 0.1
ECG response
Ischemic changes 125 (29%) 8 (16%) 0.02*
Nondiagnostic ECG 141 (28%) 23 (46%)
No ECG changes 247 (48%) 19 (38%)
Normal resting wall motion 268 (52%) 7 (14%) 0.002
Rest ejection fraction 56 6 9% 47 6 14 0.0001
Abnormal exercise echocardiogram 297 (58%) 43 (86%) 0.0001
Rest wall motion score index 1.2 6 0.3 1.5 6 0.5 0.0001
Exercise wall motion score index 1.3 6 0.5 1.7 6 0.5 0.0001
D Wall motion score index 0.1 6 0.2 0.2 6 0.2 0.01
Percentage of abnormal segments with exercise 23 6 28% 47 6 33% 0.0001
Percentage of ischemic segments 10 6 18% 16 6 20% 0.0049
*The p value refers to overall difference in ECG response.
ECG 5 electrocardiogram/electrocardiographic; METS 5 metabolic equivalents.
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cardiac events in the univariate analysis are demonstrated in
Table 3.
Event rates according to exercise echocardiographic
abnormalities. Hard cardiac events occurred in 45 (13%) of
340 patients with an abnormal exercise echocardiogram and
in 5 (2%) of 223 patients with a normal exercise echocar-
diogram. Event rate was lower in patients with normal as
compared to those with abnormal exercise echocardiography
at one year (0% vs. 1.9%), three years (1.8% vs. 11.9%), and
at five years (7.6% vs. 23.3%), overall p 5 0.0001. Event
rates according to the presence and severity of exercise
echocardiographic abnormalities are presented in Figures 1
and 2. Patients with multivessel distribution of echocardio-
graphic abnormalities had the highest event rate (32.8% at
five years).
Predictors of cardiac events in the multivariate analysis
models. In the multivariate analysis of clinical, exercise
ECG, and echocardiographic parameters combined, inde-
pendent predictors of hard events were a history of MI
(chi-square 5 2.1, [confidence interval] CI: 1.2–3.8, p 5
0.01) and percentage of abnormal segments with exercise
(chi-square 5 2.2, CI: 1.4–2.1, p 5 0.0001).
Using the stepwise incremental model, independent vari-
ables predictive of hard cardiac events are demonstrated in
Table 4. Exercise echocardiography provided incremental
value for risk stratification, additional to clinical and exercise
stress data as indicated by the increase of the chi-square of
the incremental model by the use of echocardiographic data
(p 5 0.0001). The most significant echocardiographic
parameters in this model were resting ejection fraction and
percentage of ischemic segments.
DISCUSSION
Recognition of the presence and severity of IHD—and,
more importantly, the risk of future cardiac events in
diabetic patients—is important for the optimization of
treatment (1,2,7–10). The value of exercise echocardiogra-
phy in the prognostic stratification of patients with known
or suspected IHD has been studied (19–22). However,
there are no previous studies describing the utility of
exercise echocardiography in the risk stratification of dia-
betic patients.
Figure 1. Kaplan-Meier curves for survival free of hard cardiac events in
patients with normal exercise echocardiogram and in patients with abnor-
malities in single-vessel and multivessel distributions.
Figure 2. Cumulative event rates from one year to five years according to
the presence and extent of exercise echocardiographic abnormalities.
Table 3. Univariate Association of Clinical, Exercise Stress Test and Echocardiographic
Variables With Risk of Cardiac Death and Nonfatal Myocardial Infarction
Clinical/Exercise Parameters x2
p
Value
Risk Ratio
(Confidence
Intervals)
Clinical Characteristics
Age* 4.6 0.03 1.34 (1.10–1.79)
Previous myocardial infarction 17.9 0.0001 3.4 (1.9–6)
Previous CABG 16.5 0.0001 3.2 (1.8–5.6)
Exercise Stress Variables
Workload (METS)*** 5 0.03 0.88 (0.79–0.98)
Echocardiographic Variables
Abnormal exercise echocardiogram 13.8 0.0002 4.5 (2.04–10)
New WMA (ischemia) 4.9 0.03 1.87 (1.07–3.3)
Percentage of abnormal segments with exercise** 38.3 0.0001 1.83 (1.26–2.21)
Percentage of ischemic segments** 15 0.0001 1.79 (1.33–2.39)
Resting ejection fraction* 34.6 0.0001 0.54 (0.43–0.66)
Resting wall motion score index*** 30 0.0001 3.85 (2.37–6.2)
Exercise wall motion score index*** 33.4 0.0001 3.4 (2.2–5.1)
D Wall motion score index*** 9 0.003 4.1 (1.64–10.4)
*Per 10 units increment; **Per 25% increment; ***Per 1 unit increment.
CABG 5 coronary artery bypass grafting surgery; METS 5 metabolic equivalents; WMA 5 wall motion abnormalities.
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The current study. In this study, 563 diabetic patients with
known or suspected IHD underwent exercise echocardiog-
raphy and were followed for a median of three years. Fifty
patients (9%) experienced hard events (23 cardiac deaths
and 27 nonfatal MI) during follow-up. The event rate was
higher in patients with abnormal as compared to patients
with normal exercise echocardiogram (11.9% vs. 1.8%,
respectively, at three years). Patients with an exercise echo-
cardiogram showing a multivessel distribution of abnormal-
ities were at the highest risk for cardiac events. Approxi-
mately one-third of these patients experienced cardiac death
or nonfatal MI during the five years following the exercise
echocardiogram. In the Bypass Angioplasty Revasculariza-
tion Investigation (BARI) trial (10), the five-year mortality
rate after coronary artery bypass grafting in diabetic patients
with multivessel disease was 8.2%. This is much lower than
the spontaneous event rate in diabetic patients with mul-
tivessel distribution of exercise echocardiographic abnor-
malities in the present study. During the first few years of
follow-up in the present study, the event rate was low for
patients with normal exercise echocardiography; none of
these patients had cardiac events at the end of the second
year. However, the event rate increased gradually after two
years to reach 7.6% by the end of the fifth year. This may be
related to the progression of IHD. A repeat stress test after
the second year may be beneficial in reassessing the risk
status of patients with an initially negative study.
Patients with an exercise echocardiogram indicative of
single-vessel IHD had a risk of hard events intermediate
between patients with a normal test and those with abnor-
malities in multivessel distribution. No cardiac events oc-
curred in the first year following the test in these patients.
However, in contrast to patients with a normal test, the
event rate began to increase after the first year. These
patients may benefit from aggressive treatment of risk
factors. If revascularization is not performed, repeating the
test after one year may be useful to detect progression of
functional abnormalities.
Independent predictors of cardiac events. In an incre-
mental multivariate analysis model, a history of previous MI
was the only clinical variable associated with increased risk
of hard events. Among exercise stress test variables, work-
load was additive to clinical parameters. Exercise echocar-
diography provided data incremental to clinical and exercise
stress parameters and increased the chi-square of the clinical
and exercise ECG model from 29 to 44.8 (p 5 0.0001). The
most powerful echocardiographic predictors were resting
ejection fraction and the percentage of ischemic segments
with exercise. These findings indicate that the prognosis in
diabetic patients is not only related to resting left ventricular
function but also to the extent of exercise-induced ischemia.
Symptoms and ECG changes. The occurrence of cardiac
death or nonfatal MI was poorly predicted by a history of
angina or angina during the test. This may be related to the
high frequency of silent ischemia in diabetic patients
(23,24). Among patients with exercise-induced ischemia
(new or worsening WMA) in our study, only 15% had
angina during the stress test, and 35% had a history of
typical angina. These data indicate that the absence of
symptoms should not be interpreted as an indicator of a low
risk status in diabetic patients. Similarly, exercise-induced
ST-segment depression was not predictive of hard cardiac
events. This may be explained by the high prevalence (29%
in this study) of nondiagnostic exercise ECG in diabetic
patients. This high prevalence of resting ECG abnormali-
ties may reflect the trend to the selection of patients with
such abnormalities for an exercise stress test with imaging.
In our study, 36% of patients with resting WMA had no
history or ECG findings suggestive of previous MI. The
higher prevalence of silent MI in diabetic patients and the
possible occurrence of left ventricular dysfunction attributed
to diabetic cardiomyopathy may explain this (25). These
findings indicate that exercise echocardiography can play an
important role in the clinical assessment of diabetic patients
by evaluation of myocardial function at rest as well as during
exercise.
Exercise capacity, expressed as METs, was related to
improved outcome. This indicates that in diabetic patients
able to exercise, an exercise stress test may be preferable to
a pharmacologic stress test because of the prognostic infor-
mation provided by the exercise capacity. However, acqui-
sition of the images after exercise may underestimate the
severity of abnormalities due to possible rapid reversibility of
ischemic changes. Pharmacologic stress echocardiography
does not suffer from this limitation (26). Nonetheless, the
present study showed that the extent of WMA immediately
after exercise was directly related to the event rate. This
study selected a population with a relatively lower risk
Table 4. Independent Predictors of Cardiac Events Using Four-Step Model
Model Parameters x2 p Value Model x2
Clinical Age 0.3 0.6 24
Male gender 0.3 0.6
Previous infarction 15 0.0001
Clinical 1 exercise stress Workload 2.1 0.14 29
Clinical, exercise stress 1
rest echocardiography
Resting ejection fraction 9.6 0.002 39.9
Clinical, exercise stress, rest
echocardiography 1
exercise echocardiography
Percentage of ischemic segments 5.6 0.02 44.8
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profile, as patients were able to exercise. Inability to exercise
is a known independent predictor of adverse outcome. This
should be of particular consideration in diabetic patients, as
the ability to exercise also indicates the absence of severe
peripheral vascular disease, with its known impact on
prognosis.
Previous studies. Bates et al. (27) studied the role of
dobutamine stress echocardiography in the stratification of
53 patients with juvenile onset, insulin-dependent diabetes
mellitus who were considered for kidney and/or pancreas
transplantation. Dobutamine stress echocardiography accu-
rately stratified patients who were at risk of future cardiac
events. Kang et al. (13) studied 1,271 patients with known
or suspected IHD who underwent thallium-201/stress
technetium-99m sestamibi dual-isotope myocardial perfu-
sion single-photon emission computed tomography with
exercise or adenosine stress testing. Patients were followed
for 23.7 6 7.7 months. The incidence of hard events was
4.3% per year. Nuclear testing added incremental value over
clinical variables.
Exercise or pharmacologic stress myocardial perfusion
imaging has been recommended by the American Heart
Association for evaluation of IHD in diabetic patients.
Echocardiography has the advantages of wider availability
and lower cost, and it avoids the injection of radioactive
material. In addition, left ventricular systolic function is
assessed. The current study indicates that exercise echocar-
diography is a useful alternative to myocardial perfusion
imaging in the evaluation of diabetic patients.
Study limitations. The type and the duration of diabetes
mellitus were not defined in this study. Therefore, the
impact of these parameters on the outcome of patients and
their correlation with echocardiographic abnormalities
could not be evaluated.
Conclusions. Exercise echocardiography is useful for risk
stratification of diabetic patients with known or suspected
IHD, and it provides prognostic information incremental to
clinical and exercise ECG variables. Patients with a normal
exercise echocardiogram have a low cardiac event rate and
can be excluded from further diagnostic evaluation for the
next two years. The prognosis of diabetic patients with
known or suspected IHD is dependent on both resting left
ventricular function and the extent of exercise-induced
myocardial ischemia. Patients with multivessel distribution
of exercise echocardiographic abnormalities are at the high-
est risk of cardiac events; one-third of these patients
experience cardiac death or nonfatal MI within five years.
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